Experience with HSP90 inhibitor AUY922 in patients with relapsed or refractory non-Hodgkin lymphoma

Lignende værker

• The dipeptidyl peptidase-IV inhibitor gemigliptin alone or in combination with NVP-AUY922 has a cytotoxic activity in thyroid carcinoma cells
  af: Si Hyoung Kim, et al.
  Udgivet: (2017-10-01)
• Experience with HSP90 inhibitor AUY922 in patients with relapsed or refractory non-Hodgkin lymphoma
  af: Yasuhiro Oki, et al.
  Udgivet: (2015-07-01)
• The potent activation of Ca2+-activated K+ current by NVP-AUY922 in the human pancreatic duct cell line (PANC-1) possibly independent of heat shock protein 90 inhibition
  af: Nai-Jung Chiang, et al.
  Udgivet: (2015-04-01)
• Elucidation of the Molecular Pathways Involved in the Protective Effects of AUY-922 in LPS-Induced Inflammation in Mouse Lungs
  af: Mohammad S. Akhter, et al.
  Udgivet: (2021-05-01)
• AUY922 improves sensitivity to sunitinib in clear cell renal cell carcinoma based on network pharmacology and in vitro experiments
  af: Zixuan Chen, et al.
  Udgivet: (2024-07-01)